IP Library › Granted Patent US 11,891,433
Granted Patent B2
US 11,891,433 · App. 17/141,566 · Granted Feb 6, 2024

Camelidae single-domain antibodies against

Inventors: Camilla A Mauzy (Enon, OH); Serge Victor Marie Muyldermans (Brussels, BE)
Assignee: United States of America as represented by the Secretary of the Air Force
C07K16/1228
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,891,433
App. No.
17/141,566
Granted
Feb 6, 2024
Kind
B2
Abstract

Single-domain antibodies (SAbs) against three Yersinia pestis surface proteins (LcrV, YscF, and F1), nucleic acid sequences encoding the SAbs, and polypeptides comprising two or more SAbs capable of recognizing two or more epitopes and/or antigens. The present invention further includes methods for preventing or treating Y. pestis infections in a patient; methods for detecting and/or diagnosing Y. pestis infections; and devices and methods for identifying and/or detecting Y. pestis on a surface and/or in an environment.

Claims (10)

1. A single-domain antibody against Yersinia pestis ( Y. pestis ) F1 protein comprising:

a first framing region (“FR”) sequence comprising SEQ ID No:90;

a first complementarity determining region (“CDR”) sequence comprising SEQ ID No:18 or SEQ ID No:19;

a second FR sequence comprising SEQ ID No:114, the first CDR sequence being positioned between the first FR sequence and the second FR sequence;

a second CDR sequence comprising SEQ ID No:47;

a third FR sequence comprising SEQ ID No: 137, the second CDR sequence being positioned between the second FR sequence and the third FR sequence;

a third CDR sequence comprising SEQ ID No.71; and

a fourth FR sequence comprising SEQ ID No:152, the third CDR sequence being positioned between the third FR sequence and the fourth FR sequence.

2. The single-domain antibody of claim 1 , further comprising:

at least one of a protein tag, a protein domain tag, or a chemical tag.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2021
From: MAUZY, CAMILLA A; MUYLDERMANS, SERGE VICTOR MARIE; VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE
To: GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE
Reel/Frame 054814/0088 →
Continuity (4)
Continuation 16023723 · Jun 29, 2018
Continuation 13906386 · May 31, 2013
Provisional Application 61653488 · May 31, 2012
Related Publication 20210147518A1 · May 20, 2021